|
|
THE INTERNATIONAL MYELOMA FOUNDATION APPLAUDS EXPANSION OF VELCADE® FOR PREVIOUSLY UNTREATED PATIENTS IN EUROPE AND CANADA
With these new approvals, patients with multiple myeloma may now receive VELCADE earlier following an initial disease diagnosis.
|
|
|
09.29.08 |
|
|
 related articles
|
|
back
print
Be the first to comment